Review article: the prevention of colorectal cancer
- PMID: 11207507
- DOI: 10.1046/j.1365-2036.2001.00934.x
Review article: the prevention of colorectal cancer
Abstract
Colorectal cancer is a leading cause of cancer mortality in the industrialized world. Survival remains poor because most cases are diagnosed at an advanced stage. It is a preventable disease as colorectal cancers usually develop slowly from an identifiable precursor lesion, the adenoma. The existing strategies for colorectal cancer prevention include dietary prevention, chemoprevention and endoscopic intervention. The exact relationship between diet, particularly fibre, and colorectal cancer remains unclear, with the most recent studies suggesting that dietary fibre may not decrease colorectal cancer risk as previously thought. Non-steroidal anti-inflammatory drugs have been shown to have a protective effect against colorectal cancer, but the adverse effect profile of the non COX-2 selective drugs, particularly the risk of gastrointestinal haemorrhage, precludes their widespread use. There is increasing evidence that colorectal cancer incidence and mortality can be decreased from endoscopic polypectomy and early detection of cancer. Faecal occult blood testing in the general population ('average-risk') has been shown in randomized trials to decrease mortality from colorectal cancer by 15--33%. Long-term results of randomized trials of the effectiveness of flexible sigmoidoscopy and colonoscopy screening in the general population are awaited. Targeting high risk individuals may also be an effective and efficient way to decrease the colorectal cancer burden. As many as 15--30% of colorectal cases may be due to hereditary factors. Individuals with one or two direct relatives affected are at moderate risk for colorectal cancer (empirical lifetime mortality from colorectal cancer approximately 10%) and approximately 2--3% of cases arise in individuals harbouring highly penetrant autosomal dominant mutations, which puts them at high-risk for colorectal cancer. Surveillance colonoscopy is offered to individuals at moderate and high risk for colorectal cancer.
Similar articles
-
Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.Curr Pharm Des. 2007;13(22):2274-82. doi: 10.2174/138161207781368783. Curr Pharm Des. 2007. PMID: 17692000 Review.
-
Review article: chemoprevention of colorectal cancer.Aliment Pharmacol Ther. 2004 Jan 1;19(1):1-24. doi: 10.1046/j.1365-2036.2003.01806.x. Aliment Pharmacol Ther. 2004. PMID: 14687163 Review.
-
Primary and secondary prevention in colorectal cancer.Acta Oncol. 2003;42(8):809-15. doi: 10.1080/02841860310010673. Acta Oncol. 2003. PMID: 14968941 Review.
-
Chemoprevention of colorectal cancer.Digestion. 2007;76(1):51-67. doi: 10.1159/000108394. Epub 2007 Oct 19. Digestion. 2007. PMID: 17947819 Review.
-
Colorectal Cancer Screening and Prevention.Am Fam Physician. 2018 May 15;97(10):658-665. Am Fam Physician. 2018. PMID: 29763272
Cited by
-
National and subnational incidence, mortality and associated factors of colorectal cancer in China: A systematic analysis and modelling study.J Glob Health. 2023 Oct 13;13:04096. doi: 10.7189/jogh.13.04096. J Glob Health. 2023. PMID: 37824177 Free PMC article.
-
Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.Cochrane Database Syst Rev. 2017 Jan 8;1(1):CD003430. doi: 10.1002/14651858.CD003430.pub2. Cochrane Database Syst Rev. 2017. PMID: 28064440 Free PMC article.
-
Colorectal cancer: from epidemiology to current treatment.Libyan J Med. 2006 Jul 28;1(1):42-59. doi: 10.4176/060714. Libyan J Med. 2006. PMID: 21526020 Free PMC article. No abstract available.
-
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction.J Gastrointest Oncol. 2022 Aug;13(4):1832-1841. doi: 10.21037/jgo-22-733. J Gastrointest Oncol. 2022. PMID: 36092334 Free PMC article.
-
Overexpression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells.Cell Stress Chaperones. 2006 Autumn;11(3):199-207. doi: 10.1379/csc-180r.1. Cell Stress Chaperones. 2006. PMID: 17009592 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials